Label: WALGREENS ACNE CONTROL GEL- salicylic acid gel
- NDC Code(s): 0363-0269-83
- Packager: WALGREEN COMPANY
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated July 5, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient
- Purpose
- Uses
- Warnings
- When using this product
- Keep out of reach of children.
-
Directions
- cleanse the skin thoroughly before applying this product.
- cover the entire affected area with a thin layer one to three times daily.
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
- Other information
-
Inactive ingredients
behentrimonium methosulfate, carbomer, ceramide AP, ceramide EOP, ceramide NP, cetearyl alcohol, cetyl alcohol, chlorphenesin, cholesterol, disodium EDTA, glycerin, glycolic acid, guar hydroxypropyltrimonium chloride, lactic acid, niacinamide, phytosphingosine, sodium hyaluronate, sodium hydroxide, sodium lauroyl lactylate, water, xanthan gum
- Label
-
INGREDIENTS AND APPEARANCE
WALGREENS ACNE CONTROL GEL
salicylic acid gelProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0363-0269 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 20 mg in 1 mL Inactive Ingredients Ingredient Name Strength XANTHAN GUM (UNII: TTV12P4NEE) GLYCERIN (UNII: PDC6A3C0OX) WATER (UNII: 059QF0KO0R) CHLORPHENESIN (UNII: I670DAL4SZ) CHOLESTEROL (UNII: 97C5T2UQ7J) GLYCOLIC ACID (UNII: 0WT12SX38S) GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE (1.7 SUBSTITUENTS PER SACCHARIDE) (UNII: B16G315W7A) LACTIC ACID (UNII: 33X04XA5AT) PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q) HYALURONATE SODIUM (UNII: YSE9PPT4TH) SODIUM HYDROXIDE (UNII: 55X04QC32I) CETYL ALCOHOL (UNII: 936JST6JCN) SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO) CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) NIACINAMIDE (UNII: 25X51I8RD4) BEHENTRIMONIUM METHOSULFATE (UNII: 5SHP745C61) CERAMIDE AP (UNII: F1X8L2B00J) POLYACRYLIC ACID (8000 MW) (UNII: 73861X4K5F) CERAMIDE NP (UNII: 4370DF050B) EDETATE DISODIUM (UNII: 7FLD91C86K) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0363-0269-83 1 in 1 CARTON 05/02/2023 1 40 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final M006 05/02/2023 Labeler - WALGREEN COMPANY (008965063)